Bioreactor production of virus from adherent cells
WO2015103438A2
Oncolytic virus adjunct therapy with agents that increase virus infectivity
WO2014031693A1
Compositions containing protein polymers and vaccinia virus, and methods of use thereof
WO2013138522A2
Methods for assessing effectiveness and monitoring oncolytic virus treatment
WO2013158265A1
Imaging methods for oncolytic virus therapy
WO2013052915A2
Method for detecting replication or colonization of a biological therapeutic
CA2836299A1
Clonal strains of attenuated vaccinia viruses and methods of use thereof
WO2009126189A1
Methods and compositions for detection of bacteria and treatment of diseases and disorders
WO2009054996A2
Systems and methods for viral therapy
EP2173368A1
Use of a chemotherapeutic agent in the preparation of a medicament for treating or ameliorating an adverse side effect associated with oncolytic viral therapy
CA2690627A1
Microorganisms for imaging and/or treatment of tumors
WO2008150496A2
Assay for sensitivity to chemotherapeutic agents
AU2007231857A1
Microorganisms and cells for diagnosis and therapy of tumors
EP2426142A2
Modified vaccinia virus strains for use in a diagnostic and therapeutic method
TW200819540A
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
ZA200510193B
Modified recobinant vaccinia viruses and other micro-organisms, uses thereof
CN1839201A
Vaccinia virus recombinant and other microorganism of modifying, and use
EP1526185A1
Use of a microorganism or cell to induce autoimmunization of an organism against a tumor
EP1512746A1
Method for the production of a polypeptide, RNA or other compound in tumor tissue
NZ569767A
Microorganisms and cells for diagnosis and therapy of tumors
